Senior Development Advisor
Dan has over twenty five years experience in research and development in academia and industry. He is currently a consultant to early-stage rare disease companies and foundations, focusing on research and clinical development, and pipeline strategy. Prior to being a consultant, Dan was Chief Operating Officer at Reset Pharmaceuticals, a biotech company focused on therapeutics targeting clock proteins. His previous position was Group Vice President, Product Development and Strategy at BioMarin Pharmaceutical, a company focused on rare genetic disease, overseeing research-stage and clinical-stage core teams. Over his 15 years at BioMarin, Dan served in a variety of roles in Business Development, Product Development, and Strategy. Prior to joining BioMarin, Dan was a strategy consultant at McKinsey and Co. Dan earned a Ph.D. in entomology from UC Berkeley and an M.B.A. from the University of Chicago.